News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment


7/7/2014 7:05:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nairobi, Kenya: Malaria treatment has received a major boost after a stronger and more convenient drug for both children and adults was launched at the weekend.

The drug - Coartem 80/480 - which was launched by Novartis Pharmaceuticals Company at a Nairobi hotel, has been designed to reduce the number of tablets taken per dose.

Kenya is the third country in Africa to receive the drug that will cost Sh600 per dose.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at News Release


comments powered by Disqus
   
Malaria

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES